Those who invested in Formycon (ETR:FYB) five years ago are up 114%
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
Stay updated with breaking news from Formycon Ag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
Formycon AG's ( ETR:FYB ) price-to-sales (or "P/S") ratio of 13.2x might make it look like a strong sell right now...
Investegate announcements from Formycon AG, Formycon AG upsizes capital increase from authorized capital following strong demand
Investegate announcements from Formycon AG, Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)
Investegate announcements from Formycon AG, Formycon AG plans capital increase of approx. 5% of the share capital by way of an accelerated bookbuilding procedure to finance further growth